Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ELI LILLY & Co Director's Dealing 2021

Feb 4, 2021

29745_dirs_2021-02-03_91a776b5-f18b-4e07-becc-41240d3dc412.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2021-02-01

Reporting Person: Barnes Melissa S (Chief Eth/Cmpl Ofcr & SVP, ERM)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-02-01 Common Stock M 5445 Acquired 27425 Direct
2021-02-01 Common Stock F 2403 $207.97 Disposed 25022 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-02-01 Restricted Stock Unit $ M 5445 Disposed 2021-02-01 Common Stock (5445.0) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 927 Indirect

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.